BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 30651343)

  • 1. Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B
    Roy S; Ganguly A; Haque M; Ali H
    J Immunol; 2019 Feb; 202(4):1229-1238. PubMed ID: 30651343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally Occurring Missense MRGPRX2 Variants Display Loss of Function Phenotype for Mast Cell Degranulation in Response to Substance P, Hemokinin-1, Human β-Defensin-3, and Icatibant.
    Alkanfari I; Gupta K; Jahan T; Ali H
    J Immunol; 2018 Jul; 201(2):343-349. PubMed ID: 29794017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist.
    Bawazir M; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
    Front Immunol; 2022; 13():1033794. PubMed ID: 36275683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells
    Amponnawarat A; Chompunud Na Ayudhya C; Ali H
    Front Immunol; 2021; 12():689410. PubMed ID: 34248979
    [No Abstract]   [Full Text] [Related]  

  • 5. Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2.
    Hermans MAW; van Stigt AC; van de Meerendonk S; Schrijver B; van Daele PLA; van Hagen PM; van Splunter M; Dik WA
    Front Immunol; 2021; 12():625284. PubMed ID: 33790895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-Molecule Host-Defense Peptide Mimetic Antibacterial and Antifungal Agents Activate Human and Mouse Mast Cells via Mas-Related GPCRs.
    Alkanfari I; Freeman KB; Roy S; Jahan T; Scott RW; Ali H
    Cells; 2019 Apr; 8(4):. PubMed ID: 30987258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Regulation of Mas-Related G Protein-Coupled Receptor X2-Mediated Mast Cell Degranulation by Antimicrobial Host Defense Peptides and Porphyromonas gingivalis Lipopolysaccharide.
    Gupta K; Idahosa C; Roy S; Lee D; Subramanian H; Dhingra A; Boesze-Battaglia K; Korostoff J; Ali H
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28694291
    [No Abstract]   [Full Text] [Related]  

  • 8. Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization.
    Chompunud Na Ayudhya C; Amponnawarat A; Ali H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRGPRX2 activation as a rapid, high-throughput mechanistic-based approach for detecting peptide-mediated human mast cell degranulation liabilities.
    Lafleur MA; Werner J; Fort M; Lobenhofer EK; Balazs M; Goyos A
    J Immunotoxicol; 2020 Dec; 17(1):110-121. PubMed ID: 32525431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thimerosal induces skin pseudo-allergic reaction via Mas-related G-protein coupled receptor B2.
    Peng B; Che D; Hao Y; Zheng Y; Liu R; Qian Y; Cao J; Wang J; Zhang Y; He L; Geng S
    J Dermatol Sci; 2019 Sep; 95(3):99-106. PubMed ID: 31558225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Authentic and Ectopically Expressed MRGPRX2 Elicit Similar Mechanisms to Stimulate Degranulation of Mast Cells.
    Lazki-Hagenbach P; Ali H; Sagi-Eisenberg R
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1.
    Manorak W; Idahosa C; Gupta K; Roy S; Panettieri R; Ali H
    Respir Res; 2018 Jan; 19(1):1. PubMed ID: 29295703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel MRGPRX2 antagonists inhibit IgE-independent activation of human umbilical cord blood-derived mast cells.
    Ogasawara H; Furuno M; Edamura K; Noguchi M
    J Leukoc Biol; 2019 Nov; 106(5):1069-1077. PubMed ID: 31299111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of ryanodine-sensitive calcium store drives pseudo-allergic dermatitis
    Wang Z; Zhao X; Zhou H; Che D; Du X; Ye D; Zeng W; Geng S
    Front Immunol; 2023; 14():1207249. PubMed ID: 37404822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell degranulation via MRGPRX2 by isolated human albumin fragments.
    Karhu T; Akiyama K; Vuolteenaho O; Bergmann U; Naito T; Tatemoto K; Herzig KH
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2530-2534. PubMed ID: 28844982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants.
    Chompunud Na Ayudhya C; Amponnawarat A; Roy S; Oskeritzian CA; Ali H
    Cells; 2021 Jan; 10(1):. PubMed ID: 33467419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2.
    Kashem SW; Subramanian H; Collington SJ; Magotti P; Lambris JD; Ali H
    Eur J Pharmacol; 2011 Oct; 668(1-2):299-304. PubMed ID: 21741965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLCγ-IP3R related Ca
    Ding Y; Che D; Li C; Cao J; Wang J; Ma P; Zhao T; An H; Zhang T
    Int Immunopharmacol; 2019 Jan; 66():185-197. PubMed ID: 30471617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis.
    Kunimura K; Akiyoshi S; Uruno T; Matsubara K; Sakata D; Morino K; Hirotani K; Fukui Y
    J Allergy Clin Immunol; 2023 Jun; 151(6):1585-1594.e9. PubMed ID: 36804596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2.
    Che D; Rui L; Cao J; Wang J; Zhang Y; Ding Y; Zhao T; Ma P; An H; Gao Z; Zhang T
    Int Immunopharmacol; 2018 Sep; 62():244-250. PubMed ID: 30032049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.